News

AriBio Co., Ltd., a biotechnology company dedicated to leading the treatment of neurodegenerative diseases, announced that the National Medical Products Administration of China, along with the Center for Drug Evaluation

Brii Biosciences Limited, a leading biotechnology company, announced today that the National Medical Products Administration's Center for Drug Evaluation has granted Breakthrough Therapy Designations

PharmaTher Holdings Ltd., a specialty pharmaceutical company, has received an Amendment Acknowledgment Letter from the U.S. Food and Drug Administration for its Priority Original Abbreviated New Drug Application

The Jackson Laboratory, a nonprofit biomedical research organization, has forged a strategic partnership with AbTherx, a biotechnology innovator, to advance antibody discovery and expedite the development of vital new therapies.

Metaphore Biotechnologies, in conjunction with Flagship Pioneering, has announced a significant research collaboration with Novo Nordisk aimed at developing innovative therapeutics for managing obesity.

Neurocrine Biosciences, Inc., has announced the initiation of its Phase 1 clinical trial to evaluate NBI-1076986, a novel compound targeting the M4 subtype-selective muscarinic acetylcholine receptor.

CEL-SCI Corporation has recently shared positive news from its discussion with the U.S. Food and Drug Administration regarding the approval pathway for its cancer immunotherapy, Multikine

Acepodia, a biotech firm in the clinical stages, has released initial findings from its Phase 1 dose escalation trial of ACE1831. This therapy, a fusion of an anti-CD20 antibody with allogeneic gamma delta T cells, is aimed at treating non-Hodgkin's lymphoma

Invivyd, Inc., a biopharmaceutical company specializing in combating severe viral infections, has disclosed its intention to seek emergency use authorization from the U.S. Food and Drug Administration for pemivibart.

TC BioPharm, a biotechnology company in the clinical stage, has recently announced its intention to acquire a privately-held biotechnology company. This company specializes in the development of Chimeric Antigen Receptor T-cell